BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 30 9:34 PM | CHAN LEE | Proposed Sale | 1,044 | $323.69 | $337.9K | — | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,669 | $325.00 | $542.4K | 0(D) | View → |
| Jul 21, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Sale | 61,397 | $317.67 | $19.5M | 0(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Sale | 48,316 | $312.25 | $15.1M | 0(D) | View → |
| Jul 22, 2026 | Jul 22 8:29 PM | CHAN LEE | Proposed Sale | 2,001 | $318.69 | $637.7K | — | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Sale | 64,628 | $312.00 | $20.2M | 0(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Sale | 166,597 | $318.09 | $53.0M | 0(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Sale | 116,557 | $311.95 | $36.4M | 0(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Sale | 145,861 | $305.95 | $44.6M | 0(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Sale | 48,520 | $304.35 | $14.8M | 0(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Sale | 11,698 | $298.34 | $3.5M | 0(D) | View → |
| Jul 14, 2026 | Jul 14 8:48 PM | JOHN V OYLER | Proposed Sale | 513,574 | $303.96 | $156.1M | — | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Sale | 664 | $302.46 | $200.8K | 0(D) | View → |
| Jul 10, 2026 | Jul 10 8:36 PM | JOHN V OYLER | Proposed Sale | 150,000 | $302.83 | $45.4M | — | View → |
| Jul 10, 2026 | Jul 10 8:35 PM | PAN-OYLER FOUNDATION | Proposed Sale | 49,541 | $302.83 | $15.0M | — | View → |
| Jun 23, 2026 | Jun 25 9:15 PM | Xiaobin WuPresident and COO | Sale | 1,292 | $276.26 | $356.9K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:15 PM | John OylerDirector, Chief Executive Officer | Sale | 3,410 | $273.78 | $933.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:14 PM | Lai WangPresident, Global Head of R&D | Sale | 1,068 | $276.74 | $295.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 23 8:24 PM | LAI WANG | Proposed Sale | 1,068 | $276.74 | $295.6K | — | View → |
| Jun 23, 2026 | Jun 23 8:21 PM | XIAOBIN WU | Proposed Sale | 1,292 | $276.26 | $356.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 109,122(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,433 | — | 110,396(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,580 | — | 111,670(D) | View → |
← Previous
Page 2 of 2